CONDUCTING LOW‑FLOW ANAESTHESIA Premedication, preoxygenation and induction of sleep are performed according to the usual practice. Initiation of low‑flow anaesthesia The objective is to achieve an alveolar concentration of the anaesthetic agent that is adequate for producing surgical anaesthesia. There are different methods of achieving this objective. Use of high flows during initial phase The time constant is reduced, bringing the circuit concentration to the desired concentration rapidly. Often, an FG flow of 10 L of the desired gas concentration and 2 MAC agent concentration is used. By the end of 3 min (i.e., 3 time constants), the circuit would be brought to the desired concentration. This facilitates better denitrogenation and rapid achievement of desired concentration by counterbalancing the large uptake encountered at the start of the anaesthesia. Use of prefilled circuits Here, we use a different circuit like Magill’s for preoxygenation. Simultaneously, the circle system is fitted with a test lung and the entire circuit is filled with the gas mixture of the desired concentration. After tracheal intubation, the patient is connected to the circle system and rapid achievement of the desired concentration in the circuit occurs. Injection of volatile agent into the breathing circuit The usual requirement of anaesthetic agent is approximately 400–500 ml of vapour in the first 10 min (i.e., 40–50 ml/min). At 20°C, 1 ml liquid halothane yields 226 ml of vapour and 1 ml isoflurane yields 196 ml. About 2 ml of the liquid agent is injected in small increments into the expiratory limb of the circuit. The intermittent injections are often made in 0.2–0.5 ml aliquots manually. Alternatively, continuous infusion may be used with the added advantage of doing away with the peaks and troughs associated with intermittent injections. The accurate dose requirement is given by the formula: Priming dose (ml vapour) = Desired concentration × ([FRC + circuit volume] + [cardiac output × blood gas coefficient]) Maintenance of low‑flow anaesthesia During this phase, we need to maintain steady‑state concentration of the anaesthetic agents. Although the oxygen uptake remains constant at 200–250 ml/min, uptake of anaesthetic agents including N2O will be minimal. Therefore, the role of oxygen analyser to maintain oxygen concentration of at least 30% at all times is paramount. It is prudent to return the sampling gas (usually drawn at the rate of 200 ml/min) back to the circuit to boost the economy of FGF utilisation. It should be noted that the actual dial setting in the vapourisers often over‑estimates the actual output since the plenum vapourisers under delivers the agent at low flows. The achievement of the desired end tidal agent concentration may be measured most accurately using an agent analyser or by the haemodynamic stability. The Gothenburg technique[20] of conducting LFA is depicted in Figure 1. Termination of low flow anaesthesia Because of long‑time constants, recovery is delayed in LFA. However, switching over to high flows to accelerate the wash‑out of anaesthetic agents or use of activated charcoal to remove the potent vapours by absorption can result in rapid recovery. Nitrous oxide gets washed off while changing over to 100% oxygen.

Reading File
Asking for Preferences
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
The library FTS doesn't have a dedicated LFA block available for retrieval, but the passage itself is rich and self-contained. Here is a thorough explanation and summary of everything covered.

Low-Flow Anaesthesia (LFA) - Explained

What is Low-Flow Anaesthesia?

Low-flow anaesthesia is a technique where the fresh gas flow (FGF) is set well below the patient's minute ventilation (typically <1 L/min, sometimes as low as 0.5 L/min). This means the circle breathing system rebreathes most of the exhaled gas after CO2 has been removed by the soda-lime absorber. The key implications are:
  • Significant cost savings (less volatile agent and O2/N2O consumed)
  • Reduced theatre pollution
  • Better humidity and heat preservation for the airway
  • Requires more careful monitoring because the circuit behaves differently from high-flow systems

Phase 1: Initiation - Getting to the Target Concentration

The main challenge at the start is that uptake of both anaesthetic agent and oxygen is at its highest, and you need to rapidly fill the circuit to an adequate surgical concentration. The passage describes three strategies:

Strategy A - High-Flow Initial Phase (most common)

  • Set FGF to 10 L/min of the desired gas mixture
  • Set vaporiser to 2 MAC (twice the minimum alveolar concentration needed)
  • Run at this high flow for 3 minutes
  • Why 3 minutes? In an exponential wash-in system, one time constant = the time for the circuit concentration to reach ~63% of the input. By 3 time constants, you reach ~95% of the desired concentration
  • This also achieves denitrogenation - washing out the nitrogen that was in the patient's lungs and the circuit (residual N2 causes dilution and can be a problem later at low flows)

Strategy B - Prefilled Circuit

  • Use a separate circuit (e.g., Magill's) for preoxygenation
  • While preoxygenating, pre-fill the circle system with the desired gas mixture using a test lung attached to it
  • After intubation, connect the patient directly to the already-charged circle system
  • This achieves the desired concentration immediately at connection

Strategy C - Direct Injection of Liquid Volatile Agent

  • Bypass the vaporiser entirely - inject liquid agent directly into the expiratory limb of the circuit
  • Requirement: approximately 400-500 ml of vapour in the first 10 min (40-50 ml/min)
  • Conversion factors: 1 ml liquid halothane → 226 ml vapour; 1 ml liquid isoflurane → 196 ml
  • About 2 ml of liquid agent total, given in 0.2-0.5 ml aliquots intermittently, or by continuous infusion (smoother, avoids peaks and troughs)

The Priming Dose Formula

This formula calculates exactly how much vapour is needed to prime the system:
Priming dose (ml vapour) = Desired concentration × ([FRC + circuit volume] + [cardiac output × blood-gas partition coefficient])
Breaking this down:
  • FRC + circuit volume = the total gas volume you need to fill (functional residual capacity of the lungs + the volume of the circuit tubing/bag)
  • Cardiac output × blood-gas partition coefficient = the amount of agent that will dissolve into the blood during that initial period (agent "lost" to uptake)

Phase 2: Maintenance - Steady-State at Low Flow

Once the circuit has reached the target concentration, you reduce FGF to the low-flow rate. Key points:
ParameterDetail
O2 uptakeRemains constant at 200-250 ml/min even at steady state
Volatile agent uptakeDrops significantly - equilibrium is nearly reached
N2O uptakeAlso becomes minimal at steady state

Critical Safety Considerations

  1. Oxygen analyser is mandatory - because the FGF is very low, any dilution or mismatch can cause the inspired O2 to fall. The circuit must maintain at least 30% O2 at all times. You cannot rely on the flowmeter settings alone.
  2. Return the sampling gas - multigas analysers typically draw ~200 ml/min of gas for measurement. At low flows, this is a significant fraction of total FGF. The sampled gas must be returned to the circuit rather than vented, to maintain circuit volume and economy.
  3. Vaporiser under-delivery at low flows - plenum (pressure-compensated) vaporisers are calibrated for higher flows. At very low flows, they under-deliver the set concentration. So the dial setting overestimates what actually gets into the circuit. The most reliable way to confirm depth is:
    • An agent analyser (measures end-tidal volatile agent concentration directly)
    • Haemodynamic stability (indirect clinical measure of adequate depth)
  4. The Gothenburg Technique - a structured protocol for conducting LFA (referenced as Figure 1 in the original paper).

Phase 3: Termination - Recovery from LFA

Because of the long time constants at low flows, recovery would normally be delayed - the wash-out of volatile agents takes much longer when FGF is low.
Two strategies to speed recovery:
MethodMechanism
Switch to high FGF (wash-out)Increases the rate of agent elimination from the circuit and lungs
Activated charcoal filterPhysically adsorbs potent volatile agents from the breathing circuit
N2O eliminationWhen you switch to 100% O2, N2O washes off quickly (it is much less soluble than volatile agents)

Key Concepts Summary

ConceptSignificance
Time constantDetermines how quickly circuit concentration changes; = circuit volume / FGF
3 × time constantsAchieves ~95% of target concentration
DenitrogenationEssential before switching to low flows to avoid N2 accumulation
Blood-gas partition coefficientHigher = more agent dissolves in blood = more uptake = larger priming dose needed
MACMinimum alveolar concentration - the benchmark for surgical anaesthesia depth
Oxygen analyserNon-negotiable safety monitor in any low-flow or closed-circuit technique
In short, LFA is a precision technique that trades simplicity for economy and physiological benefit. It demands a sound understanding of gas kinetics, reliable monitoring (especially oxygen and agent analysers), and careful transition between high-flow and low-flow phases.
This is a shared conversation. Sign in to Orris to start your own chat.